Companies |
|
|---|---|
| Requirements | |
| Application Process | |
| Forms | |
Canada's Access to Medicines Regime is intended
to address public health problems afflicting many developing and least-developed
countries, especially those resulting from HIV/AIDS, tuberculosis, malaria
and other diseases. The Regime can only be successful with the participation
of
Canadian generic pharmaceutical companies. Under the Regime, the Canadian Commissioner
of Patents can issue a compulsory licence to a pharmaceutical company allowing the manufacture and export of
an
eligible drug or medical device to an eligible
importing country.
Pharmaceutical companies and medical device manufacturers can reap certain benefits by participating in the Regime:
To participate in the Regime,
a company must meet the requirements prescribed by the
Patent
Act, the
Use
of Patented Products for International Humanitarian Purposes Regulations,
the
Food
and Drugs Act and the
Food and Drug Regulations. Once
a company is granted a compulsory licence, it must meet the Conditions
of Compulsory Licences throughout the validity period of the licence.